Giubilei_2004_Dement.Geriatr.Cogn.Disord_18_338

Reference

Title : Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit? - Giubilei_2004_Dement.Geriatr.Cogn.Disord_18_338
Author(s) : Giubilei F , Calderaro C , Antonini G , Sepe-Monti M , Tisei P , Brunetti E , Marchione F , Caronti B , Pontieri FE
Ref : Dementia & Geriatric Cognitive Disorders , 18 :338 , 2004
Abstract :

There is growing interest in the characterization of peripheral blood lymphocytes (PBL) as a biological tool with which to investigate changes in the neurotransmitter-receptor system in neurodegenerative disorders. Here we show a slight decrease in acetylcholinesterase (AChE) and a significant increase in dopamine beta-hydroxylase (DBH) immunoreactivity in the PBL of patients with probable Alzheimer's disease (AD). Therapy with AChE inhibitors completely reversed the increase in DBH immunoreactivity. We hypothesize that the increase in DBH immunoreactivity may represent a compensatory response to cholinergic impairment. Our findings suggest that neurochemical interactions between the noradrenergic and cholinergic systems may be measured at a peripheral level in AD.

PubMedSearch : Giubilei_2004_Dement.Geriatr.Cogn.Disord_18_338
PubMedID: 15305112

Related information

Citations formats

Giubilei F, Calderaro C, Antonini G, Sepe-Monti M, Tisei P, Brunetti E, Marchione F, Caronti B, Pontieri FE (2004)
Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit?
Dementia & Geriatric Cognitive Disorders 18 :338

Giubilei F, Calderaro C, Antonini G, Sepe-Monti M, Tisei P, Brunetti E, Marchione F, Caronti B, Pontieri FE (2004)
Dementia & Geriatric Cognitive Disorders 18 :338